
MedPrime Technologies
AI-integrated digital microscopy platform for telepathology.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor investor investor investor investor | €0.0 | round | |
* | N/A | Seed | |
Total Funding | 000k |
Related Content
MedPrime Technologies is a medical device company established in 2014 that specializes in digital microscopy systems for pathology and telepathology. The company was founded in Thane, India, by four biomedical engineering postgraduate students from IIT Bombay: Samrat Singh (CEO), Greeshma Unnikrishnan (COO), Mahesh Kumar Rathor (CFO), and Binil Jacob (CTO). The founders shared a vision to improve healthcare accessibility and diagnostic services through digitization and automation, particularly in areas with a low pathologist-to-patient ratio.
The company's business model centers on the design, manufacture, and sale of its digital microscope product lines. MedPrime Technologies generates revenue through the sale of its devices to diagnostic labs, hospitals, and educational institutions, and is also developing a rental model for its more advanced systems to increase affordability. Its clients include prominent institutions like the All-India Institute of Medical Sciences (AIIMS), Dr. Lal Path Labs, and Apollo Diagnostics. The company's products are not regulated as medical devices as they are considered imaging systems that assist, rather than perform, the final diagnosis.
MedPrime's flagship products include the CILIKA and MICALYS lines. The CILIKA range features portable, benchtop, and transformable digital microscopes that integrate with tablets or smartphones, enabling high-resolution image and video capture, sharing, and remote viewing. This technology facilitates a hub-and-spoke model for pathology labs, where technicians in remote locations can capture sample images and have them diagnosed by pathologists in central facilities. The newer MICALYS platform is an AI-integrated system that offers advanced features like whole-slide imaging, robotic remote control of the microscope, and AI-assisted analysis for tasks like cell counting. This platform is designed to streamline workflows, enhance diagnostic precision, and enable telepathology on a broader scale.
Keywords: digital microscopy, telepathology, medical devices, diagnostic imaging, pathology automation, AI in diagnostics, remote diagnostics, whole slide imaging, laboratory equipment, healthcare technology, smartphone microscope, CILIKA, MICALYS, digital pathology, medical imaging systems, robotic microscopy, healthcare solutions, lab automation, medical diagnostics, AI-assisted diagnosis